Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Walter Bodmer

Showing results (11-20 of 39) with videos related to

Pageof 4
Sort By:
European Journal of Cancer (Oxford, England : 1990)|January 24, 2007
Cytostatic drug treatment causes seeding of gene promoter methylationAnders Bredberg, Walter Bodmer
Mutation Research|November 8, 2006
GSTM1 and GSTT1 polymorphisms as modifiers of age at diagnosis of hereditary nonpolyposis colorectal cancer (HNPCC) in a homogeneous cohort of individuals carrying a single predisposing mutationRebecca Felix, Walter Bodmer, Nicola S Fearnhead, et al.
Cancer Research|August 17, 2002
Cyclin D1 is not an essential target of beta-catenin signaling during intestinal tumorigenesis, but it may act as a modifier of disease severity in multiple intestinal neoplasia (Min) miceJenny Wilding, Josef Straub, Julie Bee, et al.
Cancer Research|January 10, 2002
Low-level microsatellite instability occurs in most colorectal cancers and is a nonrandomly distributed quantitative traitSarah Halford, Peter Sasieni, Andrew Rowan, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 14, 2024
Goblet cell differentiation subgroups in colorectal cancerGulnar Abdullayeva, Haoyu Liu, Ta-Chun Liu, et al.
Lab on a Chip|October 30, 2015
Separation of cancer cells from white blood cells by pinched flow fractionationMarie Pødenphant, Neil Ashley, Kamila Koprowska, et al.
Plos One|October 5, 2021
A novel xenonucleic acid-mediated molecular clamping technology for early colorectal cancer screeningQing Sun, Larry Pastor, Jinwei Du, et al.
Cancer Research|July 17, 2004
Array comparative genomic hybridization analysis of colorectal cancer cell lines and primary carcinomasEleanor J Douglas, Heike Fiegler, Andrew Rowan, et al.
Familial Cancer|July 20, 2010
MYH biallelic mutation can inactivate the two genetic pathways of colorectal cancer by APC or MLH1 transversionsJérémie H Lefevre, Chrystelle Colas, Florence Coulet, et al.
Cancers|June 22, 2023
mRNA-Lipid Nanoparticle (LNP) Delivery of Humanized EpCAM-CD3 Bispecific Antibody Significantly Blocks Colorectal Cancer Tumor GrowthVita Golubovskaya, John Sienkiewicz, Jinying Sun, et al.
Pageof 4

Showing results (11-20 of 39) with videos related to

Sort By:
Pageof 4
European Journal of Cancer (Oxford, England : 1990)|January 24, 2007
Cytostatic drug treatment causes seeding of gene promoter methylationAnders Bredberg, Walter Bodmer
Mutation Research|November 8, 2006
GSTM1 and GSTT1 polymorphisms as modifiers of age at diagnosis of hereditary nonpolyposis colorectal cancer (HNPCC) in a homogeneous cohort of individuals carrying a single predisposing mutationRebecca Felix, Walter Bodmer, Nicola S Fearnhead, et al.
Cancer Research|August 17, 2002
Cyclin D1 is not an essential target of beta-catenin signaling during intestinal tumorigenesis, but it may act as a modifier of disease severity in multiple intestinal neoplasia (Min) miceJenny Wilding, Josef Straub, Julie Bee, et al.
Cancer Research|January 10, 2002
Low-level microsatellite instability occurs in most colorectal cancers and is a nonrandomly distributed quantitative traitSarah Halford, Peter Sasieni, Andrew Rowan, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 14, 2024
Goblet cell differentiation subgroups in colorectal cancerGulnar Abdullayeva, Haoyu Liu, Ta-Chun Liu, et al.
Lab on a Chip|October 30, 2015
Separation of cancer cells from white blood cells by pinched flow fractionationMarie Pødenphant, Neil Ashley, Kamila Koprowska, et al.
Plos One|October 5, 2021
A novel xenonucleic acid-mediated molecular clamping technology for early colorectal cancer screeningQing Sun, Larry Pastor, Jinwei Du, et al.
Cancer Research|July 17, 2004
Array comparative genomic hybridization analysis of colorectal cancer cell lines and primary carcinomasEleanor J Douglas, Heike Fiegler, Andrew Rowan, et al.
Familial Cancer|July 20, 2010
MYH biallelic mutation can inactivate the two genetic pathways of colorectal cancer by APC or MLH1 transversionsJérémie H Lefevre, Chrystelle Colas, Florence Coulet, et al.
Cancers|June 22, 2023
mRNA-Lipid Nanoparticle (LNP) Delivery of Humanized EpCAM-CD3 Bispecific Antibody Significantly Blocks Colorectal Cancer Tumor GrowthVita Golubovskaya, John Sienkiewicz, Jinying Sun, et al.
Pageof 4